Clinical Trial

Clinical and Diagnostic Features of Endocarditis

Study acronym: ENDO-LANDSCAPE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The burden of endocarditis has changed in the last years due to an increase in percutaneous valve procedures offered to a more fragile, and old population. Therefore an update in epidemiology data is necessary. The Observational prospective multicenter study to characterize the cLinical ANd DiagnoStiC feAtures of endocarditis in the contemPorary Era, (ENDO-LANDSCAPE study) is an observational, multicenter and international study. The study has two arms: retrospective and prospective. The retrospective arm will involve collecting data from patients discharged with a diagnosis of endocarditis between 2016 and 2022. The data obtained in the retrospective arm of the study will be utilized in a power calculation to determine the sample size for the prospective arm of the study. In the prospective phase in every participating center, all patients referred for echocardiography to assess for endocarditis and those with established endocarditis independent of the screened request will be eligible. Patients will then be stratified according to the presence or abscence of endocarditis. Those with an established diagnosis of endocarditis will be prospectively followed for outcomes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-15; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT05547607
Lead Sponsor University Hospital of Ferrara
Conditions Endocarditis
Enrollment 500 participants
Start Date 2022-09-09
Primary Completion 2026-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-01